Global Transdermal Patch Market Opportunity: andgt; US$ 15 Billion
Global Transdermal Patch Clinical Pipeline: 100 Patches In Trials
Clinical Insight on 66 Commercially/Marketed Transdermal Patches
Global Transdermal Patch Clinical Trials Insight by Company, Drug Class, Indication and Patent Information
Regional Trends and Market Insight: US, Europe and Asia-Pacific
Dosage and Price Insight on Transdermal Patch
Global Transdermal Patch Market Future Prospects
The "Global Transdermal Patch Market, Dosage, Price and Clinical Trials Insight 2026" research report unravels the in-depth analysis and present statistical and non-statistical information related to the current market trends that are prevalent at the global and regional level. In addition to this, the report successfully delivers the information about the sales , dosage and price of the medications that are delivered through this route. Report also discusses the ongoing clinical and non-clinical parameters with respect to development of global transdermal patch market and highlights the need for integration of transdermal patches in existing drug delivery methodology available to pharmaceutical companies.
Since the advent of the transdermal drug delivery technique, there has been a continuous rise in the market of transdermal patches globally. The market growth is attributed to the advantages that are associated with the patch technique such as painless and non-invasive administration of the medication, ease of administration and the prolonged activation of the drug inside the body. The availability of large number of transdermal delivery system in the market is continuously proving to be a breakthrough and is currently undergoing by huge commercial success.
Transdermal patches offer many benefits over traditional drug delivery methodologies like pill, powder, or liquid medication. The most important and the fundamental benefit of using patches is the direct-to-bloodstream delivery while bypassing the liver’s metabolic activity. This method of drug delivery is therefore a boon to the patients suffering from hepatic disorders as stress to the liver is simply bypassed. A patient’s body heat activates a patch, prompting it to begin releasing medication through the skin and into the bloodstream. Thus, the innovators have enough good need for development of medications mediating through this drug delivery system.
Transdermal patches can be designed to provide prolonged and controlled release of certain drugs, which can be convenient for pain-relief drugs, nicotine, and hormone products. For instance, granisetron transdermal system is a transdermal patch used to treat chemotherapy-induced nausea and vomiting in a regulated way. The alternative forms - intravenous injections and oral tabletsandmdash;both pose challenges for patients, whereas transdermal delivery provides a more comfortable and patient-friendly delivery method.
It can be well witnessed that the patch technology is playing its part and the medication in this segment have improved a lot. Clinicians wherever possible and required are more of inclined towards its use; reasons maybe several either the condition of the patient or the extra-long duration of the therapy. The need of transdermal patch drug delivery has already gained momentum and is sure to play its part in the global pharmaceutical market.
Prologue to Transdermal Patch
1.1 Overview of Transdermal Patch
1.2 Relevance of Transdermal Patch
Types of Transdermal Patches
2.1 Single/ Multiple-Layer Drug-in-Adhesive
2.2 Reservoir Transdermal Patches
2.3 Matrix Based Transdermal Patches
2.4 Vapor Patch
2.5 Active and Passive Patch
Mechanism of Transdermal Patch Drug Delivery
3.1 Properties of Transdermal Therapeutics
3.2 Components of Transdermal Patch
3.3 Mechanism of Motion Sickness, Nicotine and Female Contraceptive Transdermal Patch
3.4 Transdermal Patch v/s Traditional Drug Delivery Methods
Global Transdermal Patch Market Insight
4.1 Global Market Scenario
4.2 Regional Market Trends
4.2.1 United States
4.2.2 Europe
4.2.3 Asia Pacific
Transdermal Patches for Cardiovascular Diseases - Availability, Dosage and Price Analysis
5.1 Clonidine Transdermal Patch (Catapres–TTS)
5.2 Nitro Glycerin Transdermal Patch
Opioid Drug Containing Transdermal Patches - Availability, Dosage and Price Analysis
Figure 4-6: Global Nicotine Transdermal Patch Market Share - Europe vs. Rest of World (%), 2019
Figure 5-1: Catapres - TTS - Price for 4 Transdermal Film Supply of 0.1mg, 0.2mg and 0.3mg Dose (US$), November’2019
Figure 5-2: Catapres - TTS - Price per Unit of 0.1mg, 0.2mg and 0.3mg Dose Transdermal Patch (US$), November’2019
Figure 5-3: Catapres - TTS - Monthly and annual Treatment cost using 0.1mg dose (US$), November’2019
Figure 5-4: Nitro TD Patch A - Price for 30 Patch supply and Price per Unit (US$), November’2019
Figure 5-5: Minitran and Nitro-Dur - Price for 30 Patch Supply of 0.1mg, 0.2mg, 0.4mg and 0.6mg Transdermal Patches (US$), November’2019
Figure 6-1: Duragesic - Price for 5 Patch Supply of 12mcg, 25mcg, 50mcg, 75mcg and 100mcg Transdermal Patches (US$), November’2019
Figure 6-2: Duragesic - Price per Unit of 12mcg, 25mcg, 50mcg, 75mcg and 100mcg Transdermal Patches (US$), November’2019
Figure 6-3: Butrans - Price for 4 Patch Supply of 5mcg, 7.5mcg, 10mcg, 15mcg and 20mcg Transdermal Patches (US$), November’2019
Figure 6-4: Butrans - Price per Unit of 5mcg, 7.5mcg, 10mcg, 15mcg and 20mcg Transdermal Patches (US$), November’2019
Figure 6-5: Generic Buprenorphine Transdermal Patch - Price for 4 Patch supply of 5mcg, 7.5mcg, 10mcg, 15mcg and 20mcg Transdermal Patches (US$), November’2019
Figure 7-1: Emsam - Price for 30 Patch Supply and Price per Unit of Various Doses of Emsam Transdermal Patches (US$), November’2019
Figure 7-2: Emsam - Monthly and Annual Treatment Cost of Parkinson’s Disease (US$), November’2019
Figure 7-3: Transderm-Scop - Price for a Supply of 4, 10 and 24 Patches of 1.5mg Transdermal Film (US$), November’2019
Figure 7-4: Generic Scopolamine Transdermal Patch - Price for a Supply of 4, 10 and 24 Patches of 1.3mg Transdermal Film (US$), November’2019
Figure 7-5: Generic Scopolamine Transdermal Patch - Price for a Supply of 4, 10 and 24 Patches of 1.5mg Transdermal Film (US$), November’2019
Figure 7-6: Exelon - Price for 30 Transdermal Patch Supply of Exelon (US$), November’2019
Figure 7-7: Generic Rivastigmine Transdermal Patch - Price for a Supply of 30 Patches of Dose 4.6mg, 9.5mg and 13.3 mg (US$), November’2019
Figure 7-8: Exelon - Initial and Maintenance Dose for the Treatment of Alzheimer and Parkinson’s Disease
Figure 7-9: Exelon - Monthly and Annual Treatment Cost for Treatment of Alzheimer and Parkinson’s Disease
Figure 7-10: Daytrana - Patent Issue and Expiration Year
Figure 7-11: Daytrana - Price for 30 Transdermal Patch Supply of All Doses (US$), November’2019
Figure 8-1: Alora - Price for a Supply of 8 Patches of Dose 0.025mg, 0.05mg, 0.075mg and 0.1mg (US$), November’2019
Figure 8-2: Alora - Price per Unit of 0.025mg, 0.05mg, 0.075mg and 0.1mg Transdermal Patch(US$), November’2019
Figure 8-3: Alora - Recommended Dose for Treatment of vaginal Atrophy and Postmenopausal Osteoporosis (mg/Day Twice in a Week), November’2019
Figure 8-4: Vivelle-Dot - Price for a Supply of 24 Patches of Dose 0.025mg, 0.0375mg, 0.05mg, 0.075mg and 0.1mg (US$), November’2019
Figure 8-5: Vivelle-Dot - Price per Unit of 0.025mg, 0.0375mg, 0.05mg, 0.075mg and 0.1mg Transdermal Patch (US$), November’2019
Figure 8-6: Recommended Dose for Treatment of vaginal Atrophy, vasomotor Symptoms, and Postmenopausal Osteoporosis (mg/Day), November’2019
Figure 8-7: Androderm - Price for 60 patch Supply and per Unit Price of 2mg Transdermal Patch (US$), November’2019
Figure 8-8: Androderm - Price for 30 patch Supply and per Unit Price of 4mg Transdermal Patch (US$), November’2019
Figure 8-9: Androderm - Recommended Initial and Maintenance Dose For Treatment of Hypogonadism (mg/day), November’2019
Figure 8-10: Ortho Evara - FDA approval and Withdrawal Year
Figure 8-11: Xulane - Price for a Supply of 3 Patches and Price per Unit of 35mcg-150mcg Transdermal Patch (US$), November 2019
Figure 8-12: Xulane - Recommended Schedule for Achieving Birth Control Effect (Days)
Figure 9-1: Nicoderm CQ - Price for a Supply of 14 Transdermal Patches of Doses 7mg, 14mg and 21mg (US$), November’2019
Figure 9-2: Nicoderm CQ - Price per Unit of 7mg, 14mg and 21mg Transdermal Patch (US$), November’2019
Figure 9-3: Nicoderm CQ - Recommended Dose and Treatment Schedule for Patients with Consumption More Than 10 Cigarette/Days (mg/day)
Figure 9-4: Nicoderm CQ - Recommended Dose and Treatment Schedule for Patients with Consumption of Less Than 10 Cigarette/Days (mg/day)
Figure 9-5: Nicoderm CQ - Full Treatment Cost for Patient with Daily Consumption of Less than 10 Cigarettes and More than 10 Cigarettes (US$), November’2019
Figure 9-6: Oxytrol - Patent Issue and Expiration Year
Figure 9-7: Oxytrol - Price of 4 Patch Supply and Price per Unit of 3.9mg Transdermal Patch (US$), November’2019
Figure 9-8: Oxytrol - Price of 8 Patch Supply and Price per Unit of 3.9mg Transdermal Patch (US$), November’2019
Figure 10-1: Global - Transdermal Patch Pipeline by Phase (%), 2019 till 2026
Figure 10-2: Global - Transdermal Patch Pipeline by Phase (Number), 2019 till 2026
Figure 10-3: Global - Transdermal Patch Pipeline by Region (%), 2019 till 2026
Figure 10-4: Global - Transdermal Patch Pipeline by Country (Number), 2019 till 2026
Figure 10-5: Global - Transdermal Patch Pipeline by Drug Class/Molecule (%), 2019 till 2026
Figure 10-6: Global - Transdermal Patch Pipeline by Company (%), 2019 till 2026
Figure 10-7: Global - Transdermal Patch Pipeline by Orphan and Fast Track Status (%), 2019 till 2026
Figure 10-8: Global - Transdermal Patch Pipeline by Mode of Action (%), 2019 till 2026
